 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- ||| HR19042 / Jiangsu Hengrui Pharma
Enrollment open: A Study to Evaluate the Efficacy and Safety of HR19042 Capsules in the Treatment of Autoimmune Hepatitis. (clinicaltrials.gov) - Aug 21, 2023
P2, N=81, Recruiting, Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Not yet recruiting --> Recruiting
- |||| HR19042 / Jiangsu Hengrui Medicine
New P2 trial: A Study to Evaluate the Efficacy and Safety of HR19042 Capsules in the Treatment of Autoimmune Hepatitis. (clinicaltrials.gov) - Jul 27, 2022
P2, N=81, Not yet recruiting, Sponsor: Jiangsu HengRui Medicine Co., Ltd.
- |||| HR19042 / Jiangsu Hengrui Medicine
Enrollment open: A Study to Evaluate the Efficacy and Safety of HR19042 Capsules in the Treatment of Primary IgA Nephropathy. (clinicaltrials.gov) - Oct 12, 2021
P2, N=210, Recruiting, Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- || HR19042 / Jiangsu Hengrui Pharma
Trial completion: A Trial of HR19042 Capsule in Healthy Chinese Subjects (clinicaltrials.gov) - Sep 24, 2021
P1, N=12, Completed, Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Not yet recruiting --> Recruiting Not yet recruiting --> Completed
- ||||| HR19042 / Jiangsu Hengrui Medicine
New P2 trial: A Study to Evaluate the Efficacy and Safety of HR19042 Capsules in the Treatment of Primary IgA Nephropathy. (clinicaltrials.gov) - Aug 23, 2021
P2, N=210, Not yet recruiting, Sponsor: Jiangsu HengRui Medicine Co., Ltd.
- || HR19042 / Jiangsu Hengrui Pharma
New P1 trial: A Trial of HR19042 Capsule in Healthy Chinese Subjects (clinicaltrials.gov) - May 13, 2021
P1, N=12, Not yet recruiting, Sponsor: Jiangsu HengRui Medicine Co., Ltd.